Search
for
Sort by
Research 61–90 of 302
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Estimation of health utility values for alopecia areata
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Alopecia in Children
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Hair Disorders in Autoimmune Diseases
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Real-world evidence in alopecia areata treatment: A narrative review
- Unlocking the Potential of Rosemary in Alopecia: A Narrative Review of Evidence on Mechanism, Applications and Challenges
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata